CoChat

Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets

Open access
Baldauf, Michaela C., Orth, Martin F., Dallmayer, Marlene, Marchetto, Aruna, Gerke, Julia S., Rubio, Rebeca Alba, Kiran, Merve M., Musa, Julian, Knott, Maximilian M. L., Ohmura, Shunya, Li, Jing, Akpolat, Nusret, Akatli, Ayse N., Özen, Özlem, Dirksen, Uta, Hartmann, Wolfgang, de Alava, Enrique, Baumhoer, Daniel, Sannino, Giuseppina, Kirchner, Thomas, Grünewald, Thomas G. P. · 2018 · Oncotarget
Cited by 87

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

// Michaela C. Baldauf 1,* , Martin F. Orth 1,* , Marlene Dallmayer 1,* , Aruna Marchetto 1 , Julia S. Gerke 1 , Rebeca Alba Rubio 1 , Merve M. Kiran 2 , Julian Musa 1 , Maximilian M. L. Knott 1 , Shunya Ohmura 1 , Jing Li 1 , Nusret Akpolat 3 , Ayse N. Akatli 3 , Özlem Özen 4 , Uta Dirksen 5 , Wolfgang Hartmann 6 , Enrique de Alava 7 , Daniel Baumhoer 8 , Giuseppina Sannino 1 , Thomas Kirchner 9,10,11 and Thomas G. P. Grünewald 1,9,10,11 1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany 2 Department of Pathology, Medical Faculty, Ankara Yildirim Beyazit University, Ankara, Turkey 3 Department of Pathology, Turgut Ozal Medical Center, Inonu University, Malatya, Turkey 4 Department of Pathology, Başkent University Hospital, Ankara, Turkey 5 Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany 6 Gerhard-Domagk-Institute for Pathology, University Hospital Münster, Westfalian Wilhelms University, Münster, Germany 7 Institute of Biomedicine of Seville (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, CIBERONC, Seville, Spain 8 Bone Tumour Reference Center, Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland 9 Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany 10 German Cancer Consortium (DKTK), Heidelberg, Germany 11 German Cancer Research Center (DKFZ), Heidelberg, Germany * These authors have contributed equally to this work Correspondence to: Thomas G. P. Grünewald, email: // Keywords : Ewing sarcoma, Ewing-like sarcoma, immunohistochemistry, BCL11B, GLG1 Received : July 18, 2017 Accepted : July 23, 2017 Published : August 04, 2017 Abstract Ewing sarcoma is an undifferentiated small-round-cell sarcoma. Although molecular detection of pathognomonic EWSR1-ETS fusions such as EWSR1-FLI1 enables definitive diagnosis, substantial confusion can arise if molecular diagnostics are unavailable. Diagnosis based on the conventional immunohistochemical marker CD99 is unreliable due to its abundant expression in morphological mimics. To identify novel diagnostic immunohistochemical markers for Ewing sarcoma, we performed comparative expression analyses in 768 tumors representing 21 entities including Ewing-like sarcomas, which confirmed that CIC-DUX4- , BCOR-CCNB3- , EWSR1-NFATc2- , and EWSR1-ETS -translocated sarcomas are distinct entities, and revealed that ATP1A1 , BCL11B , and GLG1 constitute specific markers for Ewing sarcoma. Their high expression was validated by immunohistochemistry and proved to depend on EWSR1-FLI1-binding to highly active proximal super-enhancers. Automated cut-off-finding and combination-testing in a tissue-microarray comprising 174 samples demonstrated that detection of high BCL11B and/or GLG1 expression is sufficient to reach 96% specificity for Ewing sarcoma. While 88% of tested Ewing-like sarcomas displayed strong CD99-immunoreactivity, none displayed combined strong BCL11B- and GLG1-immunoreactivity. Collectively, we show that ATP1A1 , BCL11B , and GLG1 are EWSR1-FLI1 targets, of which BCL11B and GLG1 offer a fast, simple, and cost-efficient way to diagnose Ewing sarcoma by immunohistochemistry. These markers may significantly reduce the number of misdiagnosed patients, and thus improve patient care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.20098

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

Metadata

Authors
Baldauf, M. C., Orth, M. F., Dallmayer, M., Marchetto, A., Gerke, J. S., Rubio, R. A., Kiran, M. M., Musa, J., Knott, M. M. L., Ohmura, S., Li, J., Akpolat, N., Akatli, A. N., Özen, Ö., Dirksen, U., Hartmann, W., de Alava, E., Baumhoer, D., Sannino, G., Kirchner, T., & Grünewald, T. G. P.
Venue
Oncotarget
Published
2017-08-04
Volume
9
Issue
2
Pages
1587-1601
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2950426772
Cited by
87
References
7
FWCI
5.67
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.